Company Ticker News October 28, 2021Merck Sees Up To $1 Billion In Covid Antiviral Pill Sales—It Just Needs Regulatory Approval 0 0 Share
Company Ticker News October 28, 2021Merck & Co., Inc. (MRK) CEO Bill Rogers on Q3 2021 results - Earnings Call Transcript 0 0 Share
Company Ticker News October 23, 2021Can Merck's Antiviral for COVID Succeed Where Gilead's Failed? 0 0 Share
Company Ticker News October 22, 2021Merck (MRK) Expected to Beat Earnings Estimates: Should You Buy? 0 0 Share
Press Release October 21, 2021CDC ACIP Unanimously Votes to Provisionally Recommend Merck's VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in Series with PNEUMOVAX ® 23 (Pneumococcal Vaccine Polyvalent) as an Option for Pneumococcal Vaccination in Appropriate Adults 0 0 Share
Company Ticker News October 21, 2021Merck (MRK) Outpaces Stock Market Gains: What You Should Know 0 0 Share
Press Release October 20, 2021Merck Issues Voluntary Nationwide Recall of CUBICIN® (daptomycin for injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles 0 0 Share
